BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1450410)

  • 41. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
    Hsu HL; Wadman I; Tsan JT; Baer R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The SCL gene: from case report to critical hematopoietic regulator.
    Begley CG; Green AR
    Blood; 1999 May; 93(9):2760-70. PubMed ID: 10216069
    [No Abstract]   [Full Text] [Related]  

  • 43. Nuclear localization of the SCL/TAL1 basic helix-loop-helix protein is not dependent on the presence of the basic domain.
    Bernard M; Smit L; Macintyre E; Matthieu-Mahul D; Pulford K
    Blood; 1995 Jun; 85(11):3356-7. PubMed ID: 7756670
    [No Abstract]   [Full Text] [Related]  

  • 44. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular cloning and chromosomal localization of the murine homolog of the human helix-loop-helix gene SCL.
    Begley CG; Visvader J; Green AR; Aplan PD; Metcalf D; Kirsch IR; Gough NM
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):869-73. PubMed ID: 1704135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages.
    Porcher C; Swat W; Rockwell K; Fujiwara Y; Alt FW; Orkin SH
    Cell; 1996 Jul; 86(1):47-57. PubMed ID: 8689686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcription of tal-1, a putative oncogene playing an important role in childhood T-ALL, can be shown in normal peripheral blood cells by a highly sensitive RT-PCR assay.
    Anderegg B; Horstmann M; Ernst M; Kabisch H
    Pediatr Hematol Oncol; 1997; 14(4):349-58. PubMed ID: 9211539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-range comparison of human and mouse SCL loci: localized regions of sensitivity to restriction endonucleases correspond precisely with peaks of conserved noncoding sequences.
    Göttgens B; Gilbert JG; Barton LM; Grafham D; Rogers J; Bentley DR; Green AR
    Genome Res; 2001 Jan; 11(1):87-97. PubMed ID: 11156618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
    Xia Y; Hwang LY; Cobb MH; Baer R
    Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.
    Robb L; Rasko JE; Bath ML; Strasser A; Begley CG
    Oncogene; 1995 Jan; 10(1):205-9. PubMed ID: 7824274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia.
    Xia Y; Brown L; Yang CY; Tsan JT; Siciliano MJ; Espinosa R; Le Beau MM; Baer RJ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11416-20. PubMed ID: 1763056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines.
    Leroy-Viard K; Vinit MA; Lecointe N; Mathieu-Mahul D; Roméo PH
    Blood; 1994 Dec; 84(11):3819-27. PubMed ID: 7949138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products.
    Prasad KS; Jordan JE; Koury MJ; Bondurant MC; Brandt SJ
    J Biol Chem; 1995 May; 270(19):11603-11. PubMed ID: 7744799
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.
    Shivdasani RA; Mayer EL; Orkin SH
    Nature; 1995 Feb; 373(6513):432-4. PubMed ID: 7830794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptional regulation of the stem cell leukemia gene by PU.1 and Elf-1.
    Bockamp EO; Fordham JL; Göttgens B; Murrell AM; Sanchez MJ; Green AR
    J Biol Chem; 1998 Oct; 273(44):29032-42. PubMed ID: 9786909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.
    Chervinsky DS; Zhao XF; Lam DH; Ellsworth M; Gross KW; Aplan PD
    Mol Cell Biol; 1999 Jul; 19(7):5025-35. PubMed ID: 10373552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene.
    Wang J; Jani-Sait SN; Escalon EA; Carroll AJ; de Jong PJ; Kirsch IR; Aplan PD
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3497-502. PubMed ID: 10737801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The stem cell leukaemia (SCL) gene: a critical regulator of haemopoietic and vascular development.
    Barton LM; Göttgens B; Green AR
    Int J Biochem Cell Biol; 1999 Oct; 31(10):1193-207. PubMed ID: 10582347
    [No Abstract]   [Full Text] [Related]  

  • 59. Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma.
    Hosler GA; Bash RO; Bai X; Jain V; Scheuermann RH
    Am J Pathol; 1999 Apr; 154(4):1023-35. PubMed ID: 10233841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
    Huang S; Qiu Y; Stein RW; Brandt SJ
    Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.